Tag: Cancer: Lung
Sublobar Resection Not Inferior to Lobar Resection for T1aN0 NSCLC
Sublobar resection is noninferior for disease-free and overall survival for patients with tumors ≤2 cm
Lung Cancer Screening Based on Personal Risk Is Cost-Effective
Risk model-based lung cancer screening strategy more cost-effective than 2021 USPSTF recommendations
NSCLC Survival Improved With FDG PET/CT Imaging Before Radiation Therapy
Despite NCCN guidelines recommending FDG PET/CT, 43.6 percent of patients were imaged with CT alone before subsequent radiation therapy
Model Can Accurately Predict Future Lung Cancer Risk From Low-Dose CT
Sybil achieved areas under receiver operating characteristic curve of 0.92, 0.86, and 0.94 on three external validation sets
Robotic Bronchoscopy Plus Advanced Imaging Accurate for Diagnosing Lung Malignancy
Shape-sensing robotic-assisted bronchoscopy with imaging has high diagnostic accuracy, sensitivity, specificity
Gastroesophageal Reflux Disease Causally Linked to Lung Cancer
Based on inverse variance weighted method, GERD found to substantially increase lung cancer risk
RSNA: 20-Year Survival Shows Lung Cancer Screening Effective
Furthermore, consistency of lung cancer may be an important predictor of survival
More Frequent Scans Not Linked to Improved Survival After Lung Cancer Surgery
More frequent surveillance not linked to longer recurrence-free, overall survival in pathologic stage I non-small cell lung cancer
Decrease Noted in Lung Cancer Cases Over Past Five Years
However, screening of high-risk individuals for lung cancer is still low at 5.8 percent nationally
FDA Approves Drug Combo for Metastatic Non-Small Cell Lung Cancer
Approval is for tremelimumab in combination with durvalumab and platinum-based chemotherapy
